Investigating how Chlamydia bacteria develop at the single cell level
Understanding the chlamydial developmental cycle at the single cell level
This study is looking at how Chlamydia bacteria grow and change, which could help us understand how they cause illnesses like respiratory infections and heart disease, ultimately leading to better treatments for patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Idaho NIH-funded |
| Lab location | 1 site (Moscow, United States) |
| Project ID | NIH-11035665 on NIH RePORTER |
What this research studies
This research focuses on understanding the developmental cycle of Chlamydia bacteria, which are known to cause various human diseases. By examining the different forms these bacteria take during their life cycle, the research aims to uncover the mechanisms that regulate their development. This could lead to insights into how these pathogens contribute to diseases such as respiratory infections and atherosclerosis. Patients may benefit from a better understanding of how these infections operate and how they can be treated more effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been diagnosed with Chlamydia infections or related conditions such as atherosclerosis or respiratory diseases.
Not a fit: Patients who do not have any history of Chlamydia infections or related diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for infections caused by Chlamydia, potentially reducing the incidence of related diseases.
How similar studies have performed: Other research has shown success in understanding bacterial life cycles, but this specific focus on Chlamydia at the single cell level is relatively novel.
Where this research is happening
Moscow, United States
- University of Idaho — Moscow, United States (Active)
Researchers
- Principal investigator: Grieshaber, Scott S — University of Idaho
- Study coordinator: Grieshaber, Scott S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.